Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pharynx Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00462735
What this trial is testing

Fluorouracil, Hydroxyurea, Cetuximab and Twice-daily Intensity Radiation Therapy for Advanced Head and Neck Cancer

Who this might be right for
Head and Neck CancerCancer of the PharynxCancer of the Larynx+3 more
Johnny Kao 33
Testing effectiveness (Phase 2)Study completedNCT03389295
What this trial is testing

Reduced Target Delineation and Radiation Doses Chemoradiotherapy for Patients With Locoregionally Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Xiayun He, MD 118
Early research (Phase 1)Study completedNCT01445405
What this trial is testing

Radiation Therapy and Bortezomib and Cetuximab With or Without Cisplatin to Treat Head and Neck Cancer

Who this might be right for
Carcinoma, SquamousHead and Neck CancerOral Cancer+2 more
National Cancer Institute (NCI) 3
Large-scale testing (Phase 3)Study completedNCT00293462
What this trial is testing

GM-CSF Mouthwash for Preventing and Treating Mucositis in Patients Undergoing Radiation Therapy for Head and Neck Cancer

Who this might be right for
Head and Neck CancerMucositis OralRadiation Toxicity+1 more
Marilyn Dodd 91
Not applicableLooking for participantsNCT06682442
What this trial is testing

Induction Chemotherapy Response-Guided Radiation for EBV-Associated Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal CarcinomaStage III Nasopharyngeal Carcinoma AJCC v8Stage IVA Nasopharyngeal Carcinoma AJCC v8+2 more
University of California, San Francisco 66
Not applicableUnknownNCT05183724
What this trial is testing

Ovarian Function of Nasopharyngeal Carcinoma Women Survivors

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 602
Testing effectiveness (Phase 2)Study completedNCT02849327
What this trial is testing

Combination of Cryosurgey and NK Immunotherapy for Recurrent Pharyngeal Cancer

Who this might be right for
Recurrent Pharyngeal Cancer
Fuda Cancer Hospital, Guangzhou 30
Testing effectiveness (Phase 2)Looking for participantsNCT05628922
What this trial is testing

Modulation Therapy for Locally Advanced NPC Based on Plasma EBV DNA Level Post-ICT

Who this might be right for
Nasopharyngeal Cancer
Fudan University 198
Post-approval studies (Phase 4)UnknownNCT02293356
What this trial is testing

Phase IV Clinical Trial of Nimotuzumab in the Treatment of Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Biotech Pharmaceutical Co., Ltd. 2,000
Large-scale testing (Phase 3)UnknownNCT03403829
What this trial is testing

Maintenance Chemotherapy in High-metastatic Risk Nasopharyngeal Carcinoma Patients of N3 Stage

Who this might be right for
Nasopharyngeal Carcinoma
Fudan University 360
Testing effectiveness (Phase 2)Ended earlyNCT03799445
What this trial is testing

Ipilimumab, Nivolumab, and Radiation Therapy in Treating Patients With HPV Positive Advanced Oropharyngeal Squamous Cell Carcinoma

Who this might be right for
Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Human Papillomavirus Positive Oropharyngeal Squamous Cell Carcinoma+8 more
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT05514275
What this trial is testing

Radiotherapy Combined With Endostatin and Capecitabine for NPC

Who this might be right for
Nasopharyngeal Carcinoma
Zhejiang Cancer Hospital 41
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06174012
What this trial is testing

The Effect of Sodium Fluoride Application on the Prevention of Radiation Caries in NPC Patients

Who this might be right for
Sodium Fluoride
Sun Yat-sen University 135
Testing effectiveness (Phase 2)UnknownNCT00003251
What this trial is testing

Amifostine Plus Chemotherapy and Radiation Therapy in Treating Patients With Advanced, Unresectable Head and Neck Cancer

Who this might be right for
Drug/Agent Toxicity by Tissue/OrganHead and Neck CancerRadiation Toxicity
University of Illinois at Chicago 46
Testing effectiveness (Phase 2)UnknownNCT04508829
What this trial is testing

Anti-EGFR Therapy With IMRT Concurrent Chemoradiotherapy in Locally Advanced OPC Resistant to Induction Chemotherapy

Who this might be right for
Oropharyngeal Carcinoma
Fudan University 52
Not applicableStudy completedNCT05834712
What this trial is testing

Patients With Stage III-IVa Nasopharyngeal Carcinoma With or Without a Mobile Medical Platform Full-course Nutritional Intervention

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 224
Testing effectiveness (Phase 2)UnknownNCT04447612
What this trial is testing

Concurrent Chemoradiation and Durvalumab for Locoregionally Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
The University of Hong Kong 118
Not applicableActive Not RecruitingNCT04638465
What this trial is testing

De-Escalation Protocol Of HPV Mediated Oropharyngeal Squamous Cell Carcinoma

Who this might be right for
HPV-Mediated (P16-Positive) Oropharyngeal Carcinoma by AJCC V8 Clinical StageOropharynx Cancer
Nebraska Methodist Health System 150
Large-scale testing (Phase 3)Active Not RecruitingNCT05211232
What this trial is testing

Neoadjuvant and Adjuvant Tislelizumab for Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 450
Large-scale testing (Phase 3)Looking for participantsNCT05342792
What this trial is testing

Metronomic Capecitabine With or Without PD-1 Antibody as Adjuvant Therapy in High-risk Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 556
Next Page
37